Opsona raises EUR 33 million in series C

Opsona Therapeutics Ltd. (Dublin, Ireland) raised EUR 33 million ($43 million) in a series C round led by new investor BB Biotech Ventures and existing investor Novartis Venture Fund. Existing investors Fountain Healthcare Partners; Roche Venture Fund; and Seroba Kernel Life Sciences also participated, along with new investors Sunstone Capital; Baxter Ventures; Amgen Ventures; and EMBL Ventures. BB Biotech's Martin Muenchbach, Sunstone Capital's Magnus Corfitzen and Baxter Ventures' Geeta Vemuri joined Opsona's board. ...